Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study.
Post A, Dam WA, Sokooti S, Groothof D, Gloerich J, van Gool AJ, Kremer D, Gansevoort RT, van den Born J, Kema IP, Franssen CFM, Dullaart RPF, Bakker SJL.
Post A, et al. Among authors: dam wa.
J Clin Endocrinol Metab. 2023 May 17;108(6):1387-1393. doi: 10.1210/clinem/dgac729.
J Clin Endocrinol Metab. 2023.
PMID: 36533509
Free PMC article.